Bone matrix mineralization in osteogenesis imperfecta type VI

被引：0
|
作者：
Fratzl-Zelman, N. [1 ]
Roschger, P. [1 ]
Schmidt, I. [2 ]
Glorieux, F. [3 ,4 ]
Klaushofer, K. [1 ]
Fratzl, P. [2 ]
Wagermaier, W. [2 ]
Rauch, F. [3 ,4 ]
机构：
[1] Hanusch Hosp, Ludwig Boltzmann Inst Osteol, WGKK & AUVA Trauma Ctr Meidling, Dept Med 1, Vienna, Austria
[2] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany
[3] McGill Univ, Montreal, PQ, Canada
[4] Shriners Hosp Children, Genet Unit, Montreal, PQ, Canada
来源：
BONE | 2012年 / 51卷 / 06期
关键词：
D O I：
10.1016/j.bone.2012.08.044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [31] Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice
    Vanleene, Maximilien
    Porter, Alexandra
    Guillot, Pascale-Valerie
    Boyde, Alan
    Oyen, Michelle
    Shefelbine, Sandra
    BONE, 2012, 50 (06) : 1317 - 1323
  • [32] Effects of pamidronate on bone modeling, bone remodeling and degree of mineralization of bone from children with osteogenesis imperfecta
    Boivin, G
    Chavassieux, P
    Forin, V
    Pinto, G
    Meunier, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S24 - S24
  • [33] First use of the RANKL antibody denosumab in Osteogenesis Imperfecta Type VI
    Semler, O.
    Netzer, C.
    Hoyer-Kuhn, H.
    Becker, J.
    Eysel, P.
    Schoenau, E.
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2012, 12 (03) : 183 - 188
  • [34] Two years' experience with denosumab for children with Osteogenesis imperfecta type VI
    Hoyer-Kuhn, Heike
    Netzer, Christian
    Koerber, Friederike
    Schoenau, Eckhard
    Semler, Oliver
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
  • [35] Mutations in SERPINF1 Cause Osteogenesis Imperfecta Type VI
    Homan, Erica P.
    Rauch, Frank
    Grafe, Ingo
    Lietman, Caressa
    Doll, Jennifer A.
    Dawson, Brian
    Bertin, Terry
    Napierala, Dobrawa
    Morello, Roy
    Gibbs, Richard
    White, Lisa
    Miki, Rika
    Cohn, Daniel H.
    Crawford, Susan
    Travers, Rose
    Glorieux, Francis H.
    Lee, Brendan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (12) : 2798 - 2803
  • [36] Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI
    Heike Hoyer-Kuhn
    Christian Netzer
    Friederike Koerber
    Eckhard Schoenau
    Oliver Semler
    Orphanet Journal of Rare Diseases, 9
  • [37] BONE TURNOVER AND OSTEOGENESIS IMPERFECTA
    JETT, S
    RAMSER, JR
    FROST, HM
    VILLANUEVA, AR
    ARCHIVES OF PATHOLOGY, 1966, 81 (02): : 112 - +
  • [38] Muscle Force and Bone Strength in Osteogenesis Imperfecta Type I
    Veilleux, Louis-Nicolas
    Rauch, Frank
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [39] BONE TURNOVER IS LOW IN TYPE-I OSTEOGENESIS IMPERFECTA
    SHAPIRO, JR
    MCCARTHY, EF
    EARNEST, K
    COPLEY, C
    ROSSITER, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S301 - S301
  • [40] AN ALTERED BONE-MATRIX COMPONENT STOICHIOMETRY IS ASSOCIATED WITH OSTEOGENESIS IMPERFECTA
    FEDARKO, NS
    ROBEY, PG
    VETTER, UK
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S98 - S98
12345